Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 1999;30:1402-1408

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Charpentier, C.
Right arrow Articles by Laxenaire, M. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Charpentier, C.
Right arrow Articles by Laxenaire, M. C.
Related Collections
Right arrow Aneurysm, AVM, hematoma
Right arrow Cerebral Aneurysm, AVM, & Subarachnoid hemorrhage
Right arrow Risk Factors for Stroke

(Stroke. 1999;30:1402-1408.)
© 1999 American Heart Association, Inc.


Original Contributions

Multivariate Analysis of Predictors of Cerebral Vasospasm Occurrence After Aneurysmal Subarachnoid Hemorrhage

Claire Charpentier, MD; Gerard Audibert, MD, PhD; Francis Guillemin, MD, PhD; Thierry Civit, MD; Xavier Ducrocq, MD; Serge Bracard, MD; Henri Hepner, MD; Luc Picard, MD Marie Claire Laxenaire, MD

From the Departments of Anesthesiology (C.C., G.A., M.C.L.), Clinical Epidemiology UPRES EA 1124 (F.G.), Neurosurgery (T.C., H.H.), Neurology (X.D.), and Neuroradiology (S.B., L.P.), Nancy University Hospital, University Henri Poincaré, Nancy, France.

Correspondence to Dr Gérard Audibert, Département d'Anesthésie, Hôpital Central, 29 Avenue de Lattre de Tassigny, 54 000 Nancy, France. E-mail audibert{at}spieao.u-nancy.fr

Background and Purpose—The role of type of treatment on cerebral vasospasm occurrence after aneurysmal subarachnoid hemorrhage (SAH) has not been studied. Through multivariate analysis we determined the independent prognostic factors of the occurrence of symptomatic vasospasm following aneurysmal SAH in a study cohort of 244 patients undergoing either surgical or endovascular treatment. The prognostic factors of sequelae after aneurysmal SAH were studied as well.

Methods—Symptomatic vasospasm was defined as the association of deterioration in a patient's neurological condition between 3 and 14 days after SAH with no other explanation and an increase in mean transcranial Doppler velocities of >120 cm/s. The prognostic factors were registered on admission and during the intensive care stay.

Results—Symptomatic vasospasm occurred in 22.2% surgical patients compared with 17.2% endovascular treatment patients (P=0.37). Multivariate analysis revealed that the probability of occurrence of symptomatic vasospasm decreased with age >50 years (relative risk [RR], 0.47 [0.25 to 0.88]) and severe World Federation of Neurological Surgeons (WFNS) grade measured on admission (RR, 0.43 [0.20 to 0.90]) and increased with hyperglycemia occurring during the intensive care stay (RR, 1.94 [1.04 to 3.63]). No difference in risk of symptomatic vasospasm could be identified between surgical and endovascular treatment. Symptomatic vasospasm (OR, 4.73 [CI, 1.77 to 12.6]) as well as WFNS grade of >2 (OR, 8.95 [3.46 to 23.2]), treatment complications (OR, 8.39 [3.16 to 22.3]), and secondary brain insults were associated with an increased risk of 6-month sequelae.

Conclusions—Age <50 years, good neurological grade, and hyperglycemia were all associated with an increased risk of cerebral vasospasm whereas treatment was not. This provides a basis for future clinical prospective randomized trials comparing both treatments.


Key Words: cerebral vasospasm • endovascular therapy • prognosis • subarachnoid hemorrhage • surgical treatment




This article has been cited by other articles:


Home page
StrokeHome page
K. Tsuda, J. Frontera, and S. Mayer
Hyperglycemia and Hyperinsulinemia in Circulatory Disorder After Subarachnoid Hemorrhage
Stroke, April 1, 2006; 37(4): 944 - 945.
[Full Text] [PDF]


Home page
StrokeHome page
J. A. Frontera, A. Fernandez, J. Claassen, M. Schmidt, H. C. Schumacher, K. Wartenberg, R. Temes, A. Parra, N. D. Ostapkovich, and S. A. Mayer
Hyperglycemia After SAH: Predictors, Associated Complications, and Impact on Outcome
Stroke, January 1, 2006; 37(1): 199 - 203.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
A. A. Rabinstein, S. Weigand, J. L.D. Atkinson, and E. F.M. Wijdicks
Patterns of Cerebral Infarction in Aneurysmal Subarachnoid Hemorrhage
Stroke, May 1, 2005; 36(5): 992 - 997.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
A. B. Singhal, M. A. Topcuoglu, D. J. Dorer, C. S. Ogilvy, B. S. Carter, and W. J. Koroshetz
SSRI and statin use increases the risk for vasospasm after subarachnoid hemorrhage
Neurology, March 22, 2005; 64(6): 1008 - 1013.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
H.-K. Park, M. Horowitz, C. Jungreis, J. Genevro, C. Koebbe, E. Levy, and A. Kassam
Periprocedural Morbidity and Mortality Associated with Endovascular Treatment of Intracranial Aneurysms
AJNR Am. J. Neuroradiol., March 1, 2005; 26(3): 506 - 514.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
A J P Goddard, P P J Raju, and A Gholkar
Does the method of treatment of acutely ruptured intracranial aneurysms influence the incidence and duration of cerebral vasospasm and clinical outcome?
J. Neurol. Neurosurg. Psychiatry, June 1, 2004; 75(6): 868 - 872.
[Abstract] [Full Text] [PDF]


Home page
J. Gerontol. A Biol. Sci. Med. Sci.Home page
T. Vogel, R. Verreault, J.-F. Turcotte, M. Kiesmann, and M. Berthel
Review Article. Intracerebral Aneurysms: A Review With Special Attention to Geriatric Aspects
J. Gerontol. A Biol. Sci. Med. Sci., June 1, 2003; 58(6): M520 - 524.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
S. Bracard, A. Lebedinsky, R. Anxionnat, J. M. Neto, G. Audibert, Y. Long, and L. Picard
Endovascular Treatment of Hunt and Hess Grade IV and V Aneuryms
AJNR Am. J. Neuroradiol., June 1, 2002; 23(6): 953 - 957.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
V. Aiyagari, D. T. Cross III, E. Deibert, R. G. Dacey Jr, and M. N. Diringer
Safety of Hemodynamic Augmentation in Patients Treated With Guglielmi Detachable Coils After Acute Aneurysmal Subarachnoid Hemorrhage
Stroke, September 1, 2001; 32(9): 1994 - 1997.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
J. Claassen, G. L. Bernardini, K. Kreiter, J. Bates, Y. E. Du, D. Copeland, E. S. Connolly, and S. A. Mayer
Effect of Cisternal and Ventricular Blood on Risk of Delayed Cerebral Ischemia After Subarachnoid Hemorrhage:: The Fisher Scale Revisited
Stroke, September 1, 2001; 32(9): 2012 - 2020.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
S. Condette-Auliac, S. Bracard, R. Anxionnat, E. Schmitt, J. C. Lacour, M. Braun, J. Meloneto, A. Cordebar, L. Yin, and L. Picard
Vasospasm After Subarachnoid Hemorrhage: Interest in Diffusion-Weighted MR Imaging
Stroke, August 1, 2001; 32(8): 1818 - 1824.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. Fujioka, K. Nishio, T. Sakaki, N. Minamino, and K. Kitamura
Adrenomedullin in Patients With Cerebral Vasospasm After Aneurysmal Subarachnoid Hemorrhage
Stroke, December 1, 2000; 31 (12): 3079 - 3083.
[Full Text]


Home page
StrokeHome page
J.-i. Hamada, T. Mizuno, Y. Kai, M. Morioka, and Y. Ushio
Microcatheter Intrathecal Urokinase Infusion Into Cisterna Magna for Prevention of Cerebral Vasospasm : Preliminary Report
Stroke, September 1, 2000; 31(9): 2141 - 2148.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. van der Jagt, D. Hasan, H. W. C. Bijvoet, H. Pieterman, P. J. Koudstaal, and C. J. J. Avezaat
Interobserver variability of cisternal blood on CT after aneurysmal subarachnoid hemorrhage
Neurology, June 13, 2000; 54(11): 2156 - 2158.
[Abstract] [Full Text] [PDF]